Alpha Healthcare Acquisition Corp. III Announces Pricing of $150 Million Initial Public Offering
27 Juillet 2021 - 12:49AM
Alpha Healthcare Acquisition Corp. III (the “Company”) announced
today that it priced its initial public offering of 15,000,000
units at $10.00 per unit. The units will be listed on the Nasdaq
Capital Market (“Nasdaq”) and will begin trading on, July 27, 2021,
under the ticker symbol “ALPAU”. Each unit consists of one share of
the Company’s Class A common stock and one-fourth of one redeemable
warrant, each whole warrant entitling the holder thereof to
purchase one share of Class A common stock at a price of $11.50 per
share. Only whole warrants will be exercisable and will trade on
the Nasdaq. Once the securities comprising the units begin
separate trading, shares of the Class A common stock and warrants
are expected to be listed on Nasdaq under the symbols “ALPA” and
“ALPAW,” respectively.
The Company is a blank check company formed for
the purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business
combination with one or more businesses. While the Company may
pursue an initial business combination target in any business or
industry, it intends to focus its search on companies in the
healthcare industry in the United States. The Company is led by
Chairman and Chief Executive Officer, Rajiv Shukla, and Chief
Financial Officer, Patrick Sturgeon with Darlene DeRemer, Eugene
Podsiadlo and William Woodward serving as independent
directors.
BofA Securities, Inc. and PJT Partners LP are
acting as joint book running managers for the offering. The Company
has granted the underwriters a 45-day option to purchase up to an
additional 2,250,000 units at the initial public offering price to
cover over-allotments, if any.
The offering is being made only by means of a
prospectus. Copies of the prospectus may be obtained, when
available, from BofA Securities, Inc., 200 North College Street,
3rd Floor, Charlotte, NC 28255-0001, Attn: Prospectus
Department, or email: dg.prospectus_requests@bofa.com. A
registration statement relating to these securities has been
declared effective on July 26, 2021 by the U.S. Securities and
Exchange Commission (the "SEC"). This press release shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. The
offering is expected to close on July 29, 2021, subject to
customary closing conditions.
FORWARD-LOOKING STATEMENTSThis press
release contains statements that constitute “forward-looking
statements,” including with respect to the initial public offering.
No assurance can be given that the offering discussed above will be
completed on the terms described, or at all. Forward-looking
statements are subject to numerous conditions, many of which are
beyond the control of the Company, including those set forth in the
Risk Factors section of the Company’s registration statement and
preliminary prospectus for the offering filed with the SEC. Copies
are available on the SEC’s website, www.sec.gov. The Company
undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by
law.
ContactRajiv ShuklaAlpha Healthcare
Acquisition Corp. III(646) 494-3296info@alphaspac.com
Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024